Swiss National Bank Axsome Therapeutics, Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 61,400 shares of AXSM stock, worth $8.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,400

Previous 60,500 1.49%

Holding current value

$8.46 Million

Previous $5.44 Million 4.42%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$83.08 - $100.49 $74,772 - $90,441	900 Added 1.49%	61,400 $5.2 Million
Q4 2023 Feb 06, 2024	SELL	$57.42 - $83.61 $643,104 - $936,432	-11,200 Reduced 15.62%	60,500 $4.82 Million
Q3 2023 Nov 08, 2023	SELL	$69.25 - $82.21 $283,925 - $337,061	-4,100 Reduced 5.41%	71,700 $5.01 Million
Q2 2023 Aug 09, 2023	BUY	$58.41 - $90.35 $321,255 - $496,924	5,500 Added 7.82%	75,800 $5.45 Million
Q1 2023 May 10, 2023	SELL	$58.39 - $75.0 $157,653 - $202,500	-2,700 Reduced 3.7%	70,300 $4.34 Million
Q4 2022 Feb 08, 2023	BUY	$39.94 - $79.72 $151,772 - $302,936	3,800 Added 5.49%	73,000 $5.63 Million
Q3 2022 Nov 09, 2022	BUY	$36.06 - $69.85 $93,756 - $181,609	2,600 Added 3.9%	69,200 $3.09 Million
Q2 2022 Aug 09, 2022	BUY	$21.74 - $46.75 $186,964 - $402,050	8,600 Added 14.83%	66,600 $2.55 Million
Q1 2022 May 09, 2022	BUY	$23.7 - $41.39 $106,650 - $186,255	4,500 Added 8.41%	58,000 $2.4 Million
Q2 2021 Aug 06, 2021	SELL	$50.63 - $73.5 $531,615 - $771,750	-10,500 Reduced 16.41%	53,500 $3.61 Million
Q1 2021 May 07, 2021	BUY	$55.91 - $81.44 $44,728 - $65,152	800 Added 1.27%	64,000 $3.62 Million
Q4 2020 Feb 05, 2021	BUY	$66.31 - $86.52 $13,262 - $17,304	200 Added 0.32%	63,200 $5.15 Million
Q3 2020 Nov 09, 2020	BUY	$68.34 - $85.84 $75,174 - $94,424	1,100 Added 1.78%	63,000 $4.49 Million
Q2 2020 Aug 05, 2020	BUY	$49.87 - $98.69 $753,037 - $1.49 Million	15,100 Added 32.26%	61,900 $5.09 Million
Q1 2020 May 08, 2020	BUY	$41.2 - $101.31 $28,840 - $70,917	700 Added 1.52%	46,800 $2.75 Million
Q4 2019 Feb 06, 2020	BUY	$16.71 - $106.24 $46,788 - $297,472	2,800 Added 6.47%	46,100 $4.77 Million
Q2 2019 Aug 02, 2019	BUY	$13.46 - $25.75 $582,818 - $1.11 Million	43,300 New	43,300 $1.12 Million

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.91B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Axsome Therapeutics, Inc. Transaction History